All In MedTech

Device Trial Radar · NCT03417505

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Last checked: Nov 19, 2026Latest source record: Jan 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

21

Actual

Start

Jan 30, 2018

Primary completion

Jan 4, 2019

Study completion Jan 4, 2019

Sponsor

Lead sponsor
Tangible ScienceNot on our public-company list
Sponsor type
Industry
Collaborators
Nova Southeastern University; University of California, Davis; Illinois College of Optometry
First posted
Jan 31, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, care provider)
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Tangible Hydra-PEG is a novel coating technology designed to improve lens wettability, deposit resistance, and tear film breakup time. This is a randomized double masked cross-over study to examine contact lens discomfort and dry eye symptoms with Tangible Hydra-PEG treated scleral lens wear compared to untreated scleral lens wear in the dry eye patient population.

Conditions

  • Dry Eye
  • Dry Eye Syndromes

Interventions

  • Scleral lenses treated with Tangible Hydra-PEGDevice

    Scleral lenses treated with Tangible Hydra-PEG, a hydrophilic, PEG-based contact lens coating designed to improve lens wettability, deposit resistance, and tear film breakup time.

  • Untreated scleral lensesDevice

    Scleral lenses without the Tangible Hydra-PEG treatment will serve as a control.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Surface Tear Breakup TimeTime frame: 30 days
  2. Corneal Fluorescein StainingTime frame: 30 days
  3. Ocular Surface Disease Index (OSDI) QuestionnaireTime frame: 30 days

1 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Davis

    Sacramento, California

  • Nova Southeastern University

    Fort Lauderdale, Florida

  • Illinois College of Optometry

    Chicago, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.